Human herpesvirus 1 DNA polymerase |
MP |
= |
0.0 |
% |
Percentage of monophosphates (MP) formed in the first step of staggered assay compound was incubated with HSV-1 thymidine kinase for 4 hr |
CHEMBL1124020 |
Human herpesvirus 1 DNA polymerase |
MP |
= |
0.0 |
% |
Percentage of monophosphates (MP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night |
CHEMBL1124020 |
Human herpesvirus 1 DNA polymerase |
DP |
= |
0.0 |
% |
Percentage of diphosphates (DP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night |
CHEMBL1124020 |
Human herpesvirus 1 DNA polymerase |
TP |
= |
0.0 |
% |
Percentage of triphosphates (TP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night |
CHEMBL1124020 |
Human herpesvirus 1 DNA polymerase |
Inhibition |
= |
0.0 |
% |
Inhibition of DNA polymerase |
CHEMBL1124020 |
Unchecked |
Inhibition |
= |
12.0 |
% |
Inhibition of DNA polymerase |
CHEMBL1124020 |
Oryctolagus cuniculus |
ED50 |
= |
50.0 |
ug ml-1 |
Antiviral activity against HSV-1 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures) |
CHEMBL1124020 |
Oryctolagus cuniculus |
ED50 |
= |
50.0 |
ug ml-1 |
Antiviral activity against HSV-2 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures) |
CHEMBL1124020 |